Fulgent is a technology-based company focused on transforming care. Our clinical diagnostic services include molecular diagnostic testing, comprehensive genetic testing, and high-quality anatomic pathology laboratory services designed to provide clinically actionable diagnostic information to improve the quality of patient care. Our therapeutic development business is focused on developing drug candidates for treating a broad range of cancers using a novel nanoencapsulation and targeted therapy platform. Our aim is to be a fully integrated precision medicine company.